Aurinia Pharmaceuticals to Present at Stifel 2016 Healthcare Conference
10 November 2016 - 6:35PM
Business Wire
Aurinia Pharmaceuticals Inc., (NASDAQ:AUPH)(TSX:AUP) today
announced that its Chief Operating Officer, Michael Martin, will
present a corporate overview of the Company at the Stifle 2016
Healthcare Conference taking place November 15-16, 2016 at the
Lotte New York Palace Hotel. The presentation will also be
available via webcast at the link listed below.
Aurinia Presentation
DetailsDate: Wednesday, November 16, 2016Time: 2:15pm
ETLocation: Lotte New York Palace HotelWebcast:
http://wsw.com/webcast/stifel5/auph
About AuriniaAurinia is a clinical stage
biopharmaceutical company focused on developing and commercializing
therapies to treat targeted patient populations that are suffering
from serious diseases with a high unmet medical need. The Company
is currently developing voclosporin, an investigational drug, for
the treatment of lupus nephritis (LN), in an inflammation of the
kidney caused by Systemic Lupus Erythematosus (SLE) and represents
a serious progression of SLE. The Company is headquartered in
Victoria, BC and focuses its development efforts globally.
Visit www.auriniapharma.com for more information.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161110006276/en/
Aurinia Pharmaceuticals Inc.Investor & Media
Contact:Celia EconomidesAssociate VP, Investor
Relationsceconomides@auriniapharma.com